Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04820894

Perception of Cure Among Patients With Metastatic Cancer

The Perception of Cure Among Patients With Metastatic Cancer

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowledge) before starting immunotherapy and if differences exist in understanding of treatment to stimulate or restore the ability of the body's immune (defense) system to fight infection and disease (immunotherapy) based on social and economic factors or on race/ethnicity.

Detailed description

PRIMARY OBJECTIVE: I. To assess the proportion of patients with metastatic cancer who anticipate cure before starting immunotherapy. SECONDARY OBJECTIVES: I. To determine if expectations of cure are associated with quality of life and distress. II. To determine if patients' perceptions differ by gender, age, and ethnicity. OUTLINE: Patients complete surveys over 30 minutes about sociodemographic information and perception of immunotherapy, over 10 minutes about expectations of cure, over 10 minutes about anxiety, over 10 minutes about depression, and over 30 minutes about physical well-being. Patients' medical records are reviewed.

Conditions

Interventions

TypeNameDescription
OTHERElectronic Medical RecordMedical records are reviewed
OTHERSurvey AdministrationComplete surveys

Timeline

Start date
2021-10-30
Primary completion
2022-01-05
Completion
2022-01-05
First posted
2021-03-29
Last updated
2025-05-23

Source: ClinicalTrials.gov record NCT04820894. Inclusion in this directory is not an endorsement.